{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T13:40:44Z","timestamp":1775050844756,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.yebeh.2024.109791","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T03:33:36Z","timestamp":1713670416000},"page":"109791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Changes in pediatric referrals after the 2009 ketogenic diet consensus recommendations"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4481-4095","authenticated-orcid":false,"given":"Rebecca S.","family":"Stainman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahava","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5260-5314","authenticated-orcid":false,"given":"Eric H.","family":"Kossoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2024.109791_b0005","doi-asserted-by":"crossref","unstructured":"Kossoff EH, Zupec-Kania BA, Amark PE et al. Charlie Foundation, Practice Committee of the Child Neurology Society; Practice Committee of the Child Neurology Society; International Ketogenic Diet Study Group. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009 Feb;50(2):304-17. doi: 10.1111\/j.1528-1167.2008.01765.x. Epub 2008 Sep 23. PMID: 18823325.","DOI":"10.1111\/j.1528-1167.2008.01869.x"},{"key":"10.1016\/j.yebeh.2024.109791_b0010","doi-asserted-by":"crossref","unstructured":"Kossoff EH, Zupec-Kania BA, Auvin S et al. Charlie Foundation; Matthew's Friends; Practice Committee of the Child Neurology Society. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018 May 21;3(2):175-192. doi: 10.1002\/epi4.12225. PMID: 29881797; PMCID: PMC5983110.","DOI":"10.1002\/epi4.12225"},{"issue":"8","key":"10.1016\/j.yebeh.2024.109791_b0015","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1177\/0883073816636225","article-title":"Diet Redux: Outcomes from reattempting dietary therapy for epilepsy","volume":"31","author":"Kossoff","year":"2016","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2024.109791_b0020","first-page":"381","article-title":"Antiepileptic drug treatment of epilepsy in children","volume":"25","author":"Moosa","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.yebeh.2024.109791_b0025","unstructured":"Invitae Behind the Seizure Program. Updated 2023. Accessed October 20, 2023. https:\/\/www.invitae.com\/us\/sponsored-testing\/behind-the-seizure."},{"issue":"1","key":"10.1016\/j.yebeh.2024.109791_b0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.24970","article-title":"A simple blood test expedites the diagnosis of glucose transporter type 1 deficiency syndrome","volume":"82","author":"Gras","year":"2017","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.yebeh.2024.109791_b0035","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/jcm12072532","article-title":"Epilepsy in Dravet syndrome-current and future therapeutic opportunities","volume":"12","author":"Gao","year":"2023","journal-title":"J Clin Med"},{"issue":"382","key":"10.1016\/j.yebeh.2024.109791_b0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jns.2017.09.031","article-title":"Impact of non-guideline-based treatment of status epilepticus","volume":"15","author":"Braun","year":"2017","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.yebeh.2024.109791_b0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0040-1705121","article-title":"Infantile spasms: opportunities to improve care","volume":"40","author":"Messer","year":"2020","journal-title":"Semin Neurol"},{"key":"10.1016\/j.yebeh.2024.109791_b0050","unstructured":"Vasquez A, Ga\u00ednza-Lein M, Abend NS et al.; Pediatric Status Epilepticus Research Group (pSERG). First-line medication dosing in pediatric refractory status epilepticus. Neurology. 2020 Nov 10;95(19):e2683-e2696. doi: 10.1212\/WNL.0000000000010828. Epub 2020 Sep 10. PMID: 32913024; PMCID: PMC7713738."}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024001720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024001720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T03:13:46Z","timestamp":1726370026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505024001720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":10,"alternative-id":["S1525505024001720"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109791","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in pediatric referrals after the 2009 ketogenic diet consensus recommendations","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109791"}}